He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
PRX-PLUS has a unique product feature with its deep-impacting formula
The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system
AstraZeneca Pharma India discontinues manufacturing of Imdur
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy
Subscribe To Our Newsletter & Stay Updated
